Location History:
- Lidingo, SE (1993 - 2012)
- Lidingö, SE (2010 - 2015)
- Lindingö, SE (2014 - 2016)
Company Filing History:
8 out of 16 
1 out of 27 
1 out of 1 Years Active: 1993-2016
Title: Pär Gellerfors: Innovator in Neurodegenerative Disorder Treatments
Introduction
Pär Gellerfors is a prominent inventor based in Lidingö, Sweden. He has made significant contributions to the field of neuroscience, particularly in the development of antibodies and vaccines for neurodegenerative disorders. With a total of eight patents to his name, Gellerfors is recognized for his innovative approaches to treating conditions such as Parkinson's disease and Alzheimer's disease.
Latest Patents
Gellerfors' latest patents include groundbreaking work on antibodies and vaccines aimed at therapeutic and diagnostic methods for α-synuclein-related disorders. One notable invention involves methods for treating or delaying the onset of neurodegenerative disorders characterized by α-synuclein pathology. This method comprises administering an antibody produced from a stabilized soluble α-synuclein oligomer, which is capable of binding to the oligomer. The antibody is derived from a non-human animal that has been administered the stabilized soluble α-synuclein oligomer or produced through advanced techniques such as hybridoma technology and phage display. Another significant patent focuses on protofibril selective antibodies, which have high affinity for human Aβ protofibrils. This invention includes methods for preventing or treating Alzheimer's disease by administering the antibody or its fragments to patients.
Career Highlights
Pär Gellerfors is currently associated with Bioarctic Neuroscience AB, a company dedicated to developing innovative treatments for neurodegenerative diseases. His work has been instrumental in advancing the understanding and treatment of disorders that significantly impact patients' quality of life. Gellerfors' research has garnered attention in the scientific community, leading to numerous publications and presentations.
Collaborations
Gellerfors collaborates with notable colleagues in the field, including Lars Lannfelt and Dag Sehlin. Their combined expertise contributes to the innovative research and development efforts at Bioarctic Neuroscience AB.
Conclusion
Pär Gellerfors stands out as a key figure in the fight against neurodegenerative disorders through his innovative inventions and patents. His work continues to pave the way for new therapeutic options that could improve the lives of many individuals affected by these challenging conditions.